MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
10.1038/cddis.2013.291
Crossref journal-article
Springer Science and Business Media LLC
Cell Death & Disease (297)
Bibliography

Botta, A., Malena, A., Tibaldi, E., Rocchi, L., Loro, E., Pena, E., Cenci, L., Ambrosi, E., Bellocchi, M. C., Pagano, M. A., Novelli, G., Rossi, G., Monaco, H. L., Gianazza, E., Pantic, B., Romeo, V., Marin, O., Brunati, A. M., & Vergani, L. (2013). MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases. Cell Death & Disease, 4(8), e770–e770.

Authors 19
  1. A Botta (first)
  2. A Malena (additional)
  3. E Tibaldi (additional)
  4. L Rocchi (additional)
  5. E Loro (additional)
  6. E Pena (additional)
  7. L Cenci (additional)
  8. E Ambrosi (additional)
  9. M C Bellocchi (additional)
  10. M A Pagano (additional)
  11. G Novelli (additional)
  12. G Rossi (additional)
  13. H L Monaco (additional)
  14. E Gianazza (additional)
  15. B Pantic (additional)
  16. V Romeo (additional)
  17. O Marin (additional)
  18. A M Brunati (additional)
  19. L Vergani (additional)
References 59 Referenced 27
  1. Harper PS . Myotonic dystrophy 2nd edn. Sautnders: London 2001.
  2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992; 69: 385. / Cell by JD Brook (1992)
  3. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255: 1256–1258. (10.1126/science.1546326) / Science by YH Fu (1992)
  4. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992; 255: 1253–1255. (10.1126/science.1546325) / Science by M Mahadevan (1992)
  5. Cho DH, Tapscott SJ . Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2007; 1772: 195–204. (10.1016/j.bbadis.2006.05.013) / Biochim Biophys Acta by DH Cho (2007)
  6. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D et al. A muscleblind knockout model for myotonic dystrophy. Science 2003; 302: 1978–1980. (10.1126/science.1088583) / Science by RN Kanadia (2003)
  7. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006; 15: 2087–2097. (10.1093/hmg/ddl132) / Hum Mol Genet by X Lin (2006)
  8. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 2010; 17: 187–193. (10.1038/nsmb.1720) / Nat Struct Mol Biol by H Du (2010)
  9. Kanadia RN, Shin J, Yuan Y, Beattie SG, Wheeler TM, Thornton CA et al. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci USA 2006; 103: 11748–11753. (10.1073/pnas.0604970103) / Proc Natl Acad Sci USA by RN Kanadia (2006)
  10. Chamberlain CM, Ranum LP . Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise. Hum Mol Genet 2012; 21: 4645–4654. (10.1093/hmg/dds306) / Hum Mol Genet by CM Chamberlain (2012)
  11. Dansithong W, Paul S, Comai L, Reddy S . MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem 2005; 280: 5773–5780. (10.1074/jbc.M410781200) / J Biol Chem by W Dansithong (2005)
  12. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002; 11: 805–814. (10.1093/hmg/11.7.805) / Hum Mol Genet by M Fardaei (2002)
  13. Kino Y, Mori D, Oma Y, Takeshita Y, Sasagawa N, Ishiura S . Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet 2004; 13: 495–507. (10.1093/hmg/ddh056) / Hum Mol Genet by Y Kino (2004)
  14. Botta A, Rinaldi F, Catalli C, Vergani L, Bonifazi E, Romeo V et al. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J Med Genet 2008; 45: 639–646. (10.1136/jmg.2008.058909) / J Med Genet by A Botta (2008)
  15. Dhaenens CM, Schraen-Maschke S, Tran H, Vingtdeux V, Ghanem D, Leroy O et al. Overexpression of MBNL1 fetal isoforms and modified splicing of tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol 2008; 210: 467–478. (10.1016/j.expneurol.2007.11.020) / Exp Neurol by CM Dhaenens (2008)
  16. Teplova M, Song J, Gaw HY, Teplov A, Patel DJ . Structural insights into RNA recognition by the alternate-splicing regulator CUG-binding protein 1. Structure 2010; 18: 1364–1377. (10.1016/j.str.2010.06.018) / Structure by M Teplova (2010)
  17. Tran H, Gourrier N, Lemercier-Neuillet C, Dhaenens CM, Vautrin A, Fernandez-Gomez FJ et al. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of muscleblind-like-1 isoforms. J Biol Chem 2011; 286: 16435–16446. (10.1074/jbc.M110.194928) / J Biol Chem by H Tran (2011)
  18. Kuyumcu-Martinez NM, Wang GS, Cooper TA . Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 2007; 28: 68–78. (10.1016/j.molcel.2007.07.027) / Mol Cell by NM Kuyumcu-Martinez (2007)
  19. Pascual M, Vicente M, Monferrer L, Artero R . The muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 2006; 74: 65–80. (10.1111/j.1432-0436.2006.00060.x) / Differentiation by M Pascual (2006)
  20. Gates DP, Coonrod LA, Berglund JA . Autoregulated splicing of muscleblind-like 1 (MBNL1) pre-mRNA. J Biol Chem 2011; 286: 34224–34233. (10.1074/jbc.M111.236547) / J Biol Chem by DP Gates (2011)
  21. Kosaki A, Nelson J, Webster NJ . Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA. J Biol Chem 1998; 273: 10331–10337. (10.1074/jbc.273.17.10331) / J Biol Chem by A Kosaki (1998)
  22. Philips AV, Timchenko LT, Cooper TA . Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280: 737–741. (10.1126/science.280.5364.737) / Science by AV Philips (1998)
  23. Chong YP, Ia KK, Mulhern TD, Cheng HC . Endogenous and synthetic inhibitors of the src-family protein tyrosine kinases. Biochim Biophys Acta 2005; 1754: 210–220. (10.1016/j.bbapap.2005.07.027) / Biochim Biophys Acta by YP Chong (2005)
  24. Trentin L, Frasson M, Donella-Deana A, Frezzato F, Pagano MA, Tibaldi E et al. Geldanamycin-induced lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. Blood 2008; 112: 4665–4674. (10.1182/blood-2008-02-139139) / Blood by L Trentin (2008)
  25. Samuels AL, Klinken SP, Ingley E . Liar, a novel lyn-binding nuclear/cytoplasmic shuttling protein that influences erythropoietin-induced differentiation. Blood 2009; 113: 3845–3856. (10.1182/blood-2008-04-153452) / Blood by AL Samuels (2009)
  26. Hassan R, Suzu S, Hiyoshi M, Takahashi-Makise N, Ueno T, Agatsuma T et al. Dys-regulated activation of a src tyroine kinase hck at the golgi disturbs N-glycosylation of a cytokine receptor fms. J Cell Physiol 2009; 221: 458–468. (10.1002/jcp.21878) / J Cell Physiol by R Hassan (2009)
  27. Ingley E . Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta 2008; 1784: 56–65. (10.1016/j.bbapap.2007.08.012) / Biochim Biophys Acta by E Ingley (2008)
  28. Engen JR, Wales TE, Hochrein JM, Meyn MA 3rd, Banu Ozkan S, Bahar I et al. Structure and dynamic regulation of src-family kinases. Cell Mol Life Sci 2008; 65: 3058–3073. (10.1007/s00018-008-8122-2) / Cell Mol Life Sci by JR Engen (2008)
  29. Sicheri F, Moarefi I, Kuriyan J . Crystal structure of the src family tyrosine kinase hck. Nature 1997; 385: 602–609. (10.1038/385602a0) / Nature by F Sicheri (1997)
  30. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-src family tyrosine kinases. Mol Cell 2001; 8: 269–280. (10.1016/S1097-2765(01)00304-5) / Mol Cell by V Boonyaratanakornkit (2001)
  31. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J et al. Activation of the src-family tyrosine kinase hck by SH3 domain displacement. Nature 1997; 385: 650–653. (10.1038/385650a0) / Nature by I Moarefi (1997)
  32. Trible RP, Emert-Sedlak L, Smithgall TE . HIV-1 nef selectively activates src family kinases hck, lyn, and c-src through direct SH3 domain interaction. J Biol Chem 2006; 281: 27029–27038. (10.1074/jbc.M601128200) / J Biol Chem by RP Trible (2006)
  33. Lerner EC, Smithgall TE . SH3-dependent stimulation of src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nat Struct Biol 2002; 9: 365–369. / Nat Struct Biol by EC Lerner (2002)
  34. Porter M, Schindler T, Kuriyan J, Miller WT . Reciprocal regulation of hck activity by phosphorylation of tyr(527) and tyr(416). effect of introducing a high affinity intramolecular SH2 ligand. J Biol Chem 2000; 275: 2721–2726. (10.1074/jbc.275.4.2721) / J Biol Chem by M Porter (2000)
  35. Weng Z, Thomas SM, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C et al. Identification of src, fyn, and lyn SH3-binding proteins: Implications for a function of SH3 domains. Mol Cell Biol 1994; 14: 4509–4521. (10.1128/MCB.14.7.4509) / Mol Cell Biol by Z Weng (1994)
  36. Loro E, Rinaldi F, Malena A, Masiero E, Novelli G, Angelini C et al. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. Cell Death Differ 2010; 17: 1315–1324. (10.1038/cdd.2010.33) / Cell Death Differ by E Loro (2010)
  37. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, Swanson MS et al. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 2009; 18: 1471–1481. (10.1093/hmg/ddp058) / Hum Mol Genet by RJ Osborne (2009)
  38. Cougoule C, Carreno S, Castandet J, Labrousse A, Astarie-Dequeker C, Poincloux R et al. Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes. Traffic 2005; 6: 682–694. (10.1111/j.1600-0854.2005.00307.x) / Traffic by C Cougoule (2005)
  39. Kaplan KB, Swedlow JR, Varmus HE, Morgan DO . Association of p60c-src with endosomal membranes in mammalian fibroblasts. J Cell Biol 1992; 118: 321–333. (10.1083/jcb.118.2.321) / J Cell Biol by KB Kaplan (1992)
  40. Mohn H, Le Cabec V, Fischer S, Maridonneau-Parini I . The src-family protein-tyrosine kinase p59hck is located on the secretory granules in human neutrophils and translocates towards the phagosome during cell activation. Biochem J 1995; 309 (Pt 2): 657–665. (10.1042/bj3090657) / Biochem J by H Mohn (1995)
  41. Matsuda D, Nakayama Y, Horimoto S, Kuga T, Ikeda K, Kasahara K et al. Involvement of golgi-associated lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp Cell Res 2006; 312: 1205–1217. (10.1016/j.yexcr.2006.02.003) / Exp Cell Res by D Matsuda (2006)
  42. Kovarova M, Tolar P, Arudchandran R, Draberova L, Rivera J, Draber P . Structure–function analysis of lyn kinase association with lipid rafts and initiation of early signaling events after fcepsilon receptor I aggregation. Mol Cell Biol 2001; 21: 8318–8328. (10.1128/MCB.21.24.8318-8328.2001) / Mol Cell Biol by M Kovarova (2001)
  43. Magee T, Pirinen N, Adler J, Pagakis SN, Parmryd I . Lipid rafts: Cell surface platforms for T cell signaling. Biol Res 2002; 35: 127–131. (10.4067/S0716-97602002000200003) / Biol Res by T Magee (2002)
  44. Gulle H, Samstag A, Eibl MM, Wolf HM . Physical and functional association of fc alpha R with protein tyrosine kinase lyn. Blood 1998; 91: 383–391. (10.1182/blood.V91.2.383) / Blood by H Gulle (1998)
  45. McCabe JB, Berthiaume LG . Functional roles for fatty acylated amino-terminal domains in subcellular localization. Mol Biol Cell 1999; 10: 3771–3786. (10.1091/mbc.10.11.3771) / Mol Biol Cell by JB McCabe (1999)
  46. Sato I, Obata Y, Kasahara K, Nakayama Y, Fukumoto Y, Yamasaki T et al. Differential trafficking of src, lyn, yes and fyn is specified by the state of palmitoylation in the SH4 domain. J Cell Sci 2009; 122: 965–975. (10.1242/jcs.034843) / J Cell Sci by I Sato (2009)
  47. Tibaldi E, Venerando A, Zonta F, Bidoia C, Magrin E, Marin O et al. Interaction between the SH3 domain of src family kinases and the proline-rich motif of HTLV-1 p13: A novel mechanism underlying delivery of src family kinases to mitochondria. Biochem J 2011; 439: 505–516. (10.1042/BJ20101650) / Biochem J by E Tibaldi (2011)
  48. Grishin AV, Azhipa O, Semenov I, Corey SJ . Interaction between growth arrest-DNA damage protein 34 and src kinase lyn negatively regulates genotoxic apoptosis. Proc Natl Acad Sci USA 2001; 98: 10172–10177. (10.1073/pnas.191130798) / Proc Natl Acad Sci USA by AV Grishin (2001)
  49. Kharbanda S, Yuan ZM, Rubin E, Weichselbaum R, Kufe D . Activation of src-like p56/p53lyn tyrosine kinase by ionizing radiation. J Biol Chem 1994; 269: 20739–20743. (10.1016/S0021-9258(17)32054-9) / J Biol Chem by S Kharbanda (1994)
  50. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S et al. p27 phosphorylation by src regulates inhibition of cyclin E-Cdk2. Cell 2007; 128: 281–294. (10.1016/j.cell.2006.11.049) / Cell by I Chu (2007)
  51. Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB et al. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007; 128: 269–280. (10.1016/j.cell.2006.11.047) / Cell by M Grimmler (2007)
  52. Ikeda K, Nakayama Y, Togashi Y, Obata Y, Kuga T, Kasahara K et al. Nuclear localization of lyn tyrosine kinase mediated by inhibition of its kinase activity. Exp Cell Res 2008; 314: 3392–3404. (10.1016/j.yexcr.2008.08.019) / Exp Cell Res by K Ikeda (2008)
  53. Bergstrom Lind S, Artemenko KA, Elfineh L, Mayrhofer C, Zubarev RA, Bergquist J et al. Toward a comprehensive characterization of the phosphotyrosine proteome. Cell Signal 2011; 23: 1387–1395. (10.1016/j.cellsig.2011.03.021) / Cell Signal by S Bergstrom Lind (2011)
  54. Misteli T . RNA splicing: What has phosphorylation got to do with it? Curr Biol 1999; 9: R198–R200. (10.1016/S0960-9822(99)80128-6) / Curr Biol by T Misteli (1999)
  55. Stamm S . Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 2008; 283: 1223–1227. (10.1074/jbc.R700034200) / J Biol Chem by S Stamm (2008)
  56. Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li ZH et al. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Carcinogenesis 2011; 32: 1419–1426. (10.1093/carcin/bgr088) / Carcinogenesis by ZY Chen (2011)
  57. Wang ET, Cody NA, Jog S, Biancolella M, Wang TT, Treacy DJ et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 2012; 150: 710–724. (10.1016/j.cell.2012.06.041) / Cell by ET Wang (2012)
  58. Bonifazi E, Vallo L, Giardina E, Botta A, Novelli G . A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn Mol Pathol 2004; 13: 164–166. / Diagn Mol Pathol by E Bonifazi (2004)
  59. Bolte S, Cordelières FP . A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224: 213–232. (10.1111/j.1365-2818.2006.01706.x) / J Microsc by S Bolte (2006)
Dates
Type When
Created 12 years ago (Aug. 15, 2013, 10:07 a.m.)
Deposited 2 years, 7 months ago (Jan. 5, 2023, 7:02 p.m.)
Indexed 1 month ago (July 20, 2025, 6:46 p.m.)
Issued 12 years ago (Aug. 15, 2013)
Published 12 years ago (Aug. 15, 2013)
Published Online 12 years ago (Aug. 15, 2013)
Funders 0

None

@article{Botta_2013, title={MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases}, volume={4}, ISSN={2041-4889}, url={http://dx.doi.org/10.1038/cddis.2013.291}, DOI={10.1038/cddis.2013.291}, number={8}, journal={Cell Death & Disease}, publisher={Springer Science and Business Media LLC}, author={Botta, A and Malena, A and Tibaldi, E and Rocchi, L and Loro, E and Pena, E and Cenci, L and Ambrosi, E and Bellocchi, M C and Pagano, M A and Novelli, G and Rossi, G and Monaco, H L and Gianazza, E and Pantic, B and Romeo, V and Marin, O and Brunati, A M and Vergani, L}, year={2013}, month=aug, pages={e770–e770} }